Is cephalexin effective for treating perichondritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin is NOT Recommended for Perichondritis

Cephalexin should not be used as first-line treatment for auricular perichondritis because it lacks adequate coverage against Pseudomonas aeruginosa, the most common pathogen in this infection. Fluoroquinolones (ciprofloxacin or levofloxacin) are the recommended empiric therapy 1.

Pathogen Coverage Gap

The primary issue with cephalexin for perichondritis is its antimicrobial spectrum:

  • Pseudomonas aeruginosa is the predominant pathogen in auricular perichondritis, along with S. aureus and S. pyogenes 1
  • Cephalexin has poor in vitro activity against P. aeruginosa and should be avoided for infections where this organism is likely 2
  • First-generation cephalosporins like cephalexin "miss P. multocida and anaerobes" in similar soft tissue infections 2

Evidence-Based Treatment Recommendations

For Auricular Perichondritis:

Fluoroquinolones are the treatment of choice because they provide reliable coverage against the typical pathogens 1:

  • Ciprofloxacin or levofloxacin respond well to the most common organisms (P. aeruginosa, S. aureus, S. pyogenes) 1
  • Alternative options for hospitalized patients include clindamycin, ceftazidime, or cefepime 1

When Abscess is Present:

  • Surgical incision and drainage are often necessary 1
  • Once abscess develops, cosmetic preservation of auricular cartilage becomes difficult 1

Nuanced Consideration for Non-Abscess Cases

Recent research suggests a more nuanced approach for non-abscess perichondritis specifically:

  • One 2019 study found S. aureus was predominant (49%) in non-abscess cases, while P. aeruginosa was more common (58%) in abscess cases 3
  • In non-abscess perichondritis, antibiotics covering S. aureus showed no significant differences in clinical outcomes compared to those covering P. aeruginosa 3
  • However, this represents a minority view and the study recommends expanding coverage to include P. aeruginosa if clinical response is disappointing 3

Clinical Pitfalls to Avoid

Do not use cephalexin empirically for auricular perichondritis because:

  • The infection typically occurs within the first month after ear piercing, especially during warm weather 1
  • Minor infections can rapidly progress to perichondritis, abscess formation, and cartilage necrosis 1
  • Acute tenderness on deflecting the auricular cartilage distinguishes this deeper perichondrial infection from superficial skin infection 1
  • Treatment failure with inadequate antibiotic coverage risks permanent auricular deformity 4

Where Cephalexin IS Appropriate

Cephalexin remains effective for other skin and soft tissue infections where P. aeruginosa is not a concern 2, 5:

  • Impetigo and uncomplicated cellulitis caused by S. aureus or S. pyogenes 2, 6
  • Methicillin-susceptible staphylococcal infections 2, 7
  • Streptococcal skin infections (though penicillin remains preferred) 2, 8

References

Research

Perichondritis of the auricle: bacterial findings and clinical evaluation of different antibiotic regimens.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.